₹ 4.1 Cr
Volume transacted
26.5 K
stocks traded
Last Updated time: 18 Sep 9.00 AM
Natco Pharma Ltd
NSE: NATCOPHARM
ISIN
INE987B01026
Last updated: 18 Sep 9.00 AM
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Natco Pharma Ltd
NSE: NATCOPHARM
PRICE
₹ 1540.25
-21.30 (-1.36%)
Last updated: 18 Sep 15:30
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price | Day Open | Day High | Day Low |
---|
18 Sep 2024 | 1540.25 | 1560 | 1566.75 | 1520.05 |
17 Sep 2024 | 1561.55 | 1577 | 1583.85 | 1557.5 |
16 Sep 2024 | 1577 | 1585.85 | 1595 | 1557.9 |
13 Sep 2024 | 1582.9 | 1609.55 | 1618.35 | 1573 |
12 Sep 2024 | 1592.6 | 1596.3 | 1638.35 | 1565.65 |
11 Sep 2024 | 1592 | 1546.15 | 1622.6 | 1546.15 |
10 Sep 2024 | 1545.5 | 1564.45 | 1585 | 1535.45 |
09 Sep 2024 | 1545.75 | 1560.05 | 1561.55 | 1524.45 |
06 Sep 2024 | 1560 | 1560.2 | 1577.85 | 1532.35 |
05 Sep 2024 | 1554.2 | 1572.75 | 1598 | 1551 |
Date | Price |
---|---|
18 Sep 2024 | 1540.25 |
17 Sep 2024 | 1561.55 |
16 Sep 2024 | 1577 |
13 Sep 2024 | 1582.9 |
12 Sep 2024 | 1592.6 |
11 Sep 2024 | 1592 |
10 Sep 2024 | 1545.5 |
09 Sep 2024 | 1545.75 |
06 Sep 2024 | 1560 |
05 Sep 2024 | 1554.2 |
Company Name | ISIN Code |
---|
Cipla Ltd | INE059A01026 |
Dr Reddys Laboratories Ltd | INE089A01023 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Company Name | ISIN Code |
---|---|
Cipla Ltd | INE059A01026 |
Dr Reddys Laboratories Ltd | INE089A01023 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Last updated time: 18 Sep 9.00 AM
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Natco Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Natco Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Natco Pharma invests USD 8 mn in bio-tech firm eGenesis
Natco Pharma announced that its wholly owned Canadian subsidiary, Natco Pharma (Canada) In...
Read more
04 Sep 202412:07
Natco Pharma Canada arm invests $8 mln in eGenesis
eGenesis is engaged in using its multiplex gene editing and genome engineering platform to...
Read more
04 Sep 202412:01
Natco Pharma Ltd spurts 1.25%, up for third straight session
Natco Pharma Ltd rose for a third straight session today. The stock is quoting at Rs 1570....
Read more
23 Aug 202413:05
Natco Pharma schedules AGM
Natco Pharma announced that the 41th Annual General Meeting (AGM) of the company will be h...
Read more
12 Aug 202416:48
Board of Natco Pharma recommends dividend
Natco Pharma announced that the Board of Directors of the Company at its meeting held on 1...
Read more
12 Aug 202415:57
Natco Pharma spurts as Q1 PAT climbs 59% YoY to Rs 668 cr
Revenue from operations was at Rs 1,362.6 crore in Q1 FY25, up 19.47% from Rs 1140.5 crore...
Read more
12 Aug 202415:13
FAQs for ISIN of Natco Pharma Ltd
What is the ISIN code for Natco Pharma Ltd?
Why is Natco Pharma Ltd ISIN code important?
Can the ISIN code for Natco Pharma Ltd change?
Can I use the ISIN code for trading Natco Pharma Ltd shares?
How can I verify the ISIN code for Natco Pharma Ltd?
What happens if Natco Pharma Ltd issues new securities?
Unlimited trading at just
Rs. 199*